Economic evaluation of a randomized controlled trial comparing mifepristone and misoprostol with misoprostol alone in the treatment of early pregnancy loss.

PLoS One · 2022 · PMC8827447 · PMID 35139105

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The trial started on June 27 th 2018, and ended prematurely in January 2020 due to highly significant outcomes from the predefined interim-analysis.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.